FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980167008> ?p ?o ?g. }

• W2980167008 abstract "Abstract NUP98 gene fusions, created by non-random chromosomal translocations, are associated with a wide spectrum of high risk hematologic malignancies, and typically lead to overexpression of abdominal-b HOXA genes, a common theme shared by ∼50% of AML patients. We have generated a transgenic mouse model of the NUP98-PHF23 (NP23) gene fusion, initially identified in patients with AML, which develop AML, erythroleukemia, pre-T lymphoblastic leukemia (pre-T LBL), and a novel pre-B1 B cell acute lymphoblastic leukemia (pre-B1 ALL). A common theme in the leukemias and the premalignant hematopoietic tissues, is the overexpression of a Hoxa/b +Meis1 stem cell-like gene expression signature. GSEA analysis reveals this signature to be enriched in both human AML and ALL malignancies, and in human HSPC profiles. In addition, we found Bahcc1, a gene not previously associated with malignancy, to consistently segregate with the Hoxa/b+Meis1 signature in the NP23 leukemias and the premalignant tissues, independent of hematopoietic cell lineage. Furthermore, data-mining revealed BAHCC1 to be markedly overexpressed in AML patients with HOXA9/MEIS1 overexpression, and in a subset of MLL rearranged pre-B-ALL patients, suggesting BAHCC1 may be a previously unsuspected marker of leukemic transformation. NUP98-PHF23 belongs to a subset of fusion oncoproteins (including some MLL- and NUP98-fusions) that are potently tumorigenic and act by abrogating the normal reading, writing and erasure of histone methylation. Wild type PHF23 binds H3K4me3 residues via a PHD domain, therefore we used ChIP-seq to characterize global chromatin H3K4me3 and NP23 enrichment in NP23 leukemia derived cell lines. The vast majority (88%) of NP23 binding sites were enriched for H3K4me3 binding. Conversely, the NP23 protein co-localized at only 1.6% of all H3K4me3 enriched sites (including Hoxa, Hoxb and Meis1 loci) identifying these sites as direct targets of the NP23 fusion protein. Given that the NP23 fusion appears to function, at least in part, via binding to H3K4me3 sites at specific loci, we hypothesized that NP23 cells would be sensitive to disruption of the H3K4me4 binding by the NP23 PHD domain. Treatment of leukemic NP23 cells with Tetraethylthiuram disulfide (Disulfiram), a small molecule shown to inhibit PHD domain binding of H3K4me3 marks in vitro, rapidly and selectively killed NP23 myeloblasts but not control myeloblast cell lines (188G3, 189E6 and 32D) at 2 µM. Cell death was rapid, being 100% complete within 24 hours. Cell death was preceded by decreased levels of NP23 protein bound at target loci and decreased expression of these loci (e.g., Hoxa7/9/10, Hoxb5 and Meis1). We conclude that inhibitors of H3K4me3 PHD domain readers are promising therapeutic compounds that can kill leukemic cells driven by proteins that aberrantly read or write the histone code. The NP23 model provides a robust platform on which to identify and improve such compounds. Disclosures: Denu: Sirtris-GSK: Consultancy." @default.
• W2980167008 created "2019-10-18" @default.
• W2980167008 creator A5007841603 @default.
• W2980167008 creator A5009849578 @default.
• W2980167008 creator A5023012274 @default.
• W2980167008 creator A5026608364 @default.
• W2980167008 creator A5031025260 @default.
• W2980167008 creator A5035867793 @default.
• W2980167008 creator A5039903831 @default.
• W2980167008 creator A5049170518 @default.
• W2980167008 creator A5049775425 @default.
• W2980167008 creator A5055756816 @default.
• W2980167008 creator A5072237091 @default.
• W2980167008 creator A5077817714 @default.
• W2980167008 creator A5086156727 @default.
• W2980167008 creator A5087009038 @default.
• W2980167008 date "2013-11-15" @default.
• W2980167008 modified "2023-09-27" @default.
• W2980167008 title "Leukemia Driven By a NUP98-Phd Domain Fusion Is Highly Sensitive To Disruption Of H3K4me3-Phd Domain Binding By a Small Molecule Inhibitor" @default.
• W2980167008 doi "https://doi.org/10.1182/blood.v122.21.3759.3759" @default.
• W2980167008 hasPublicationYear "2013" @default.
• W2980167008 type Work @default.
• W2980167008 sameAs 2980167008 @default.
• W2980167008 citedByCount "0" @default.
• W2980167008 crossrefType "journal-article" @default.
• W2980167008 hasAuthorship W2980167008A5007841603 @default.
• W2980167008 hasAuthorship W2980167008A5009849578 @default.
• W2980167008 hasAuthorship W2980167008A5023012274 @default.
• W2980167008 hasAuthorship W2980167008A5026608364 @default.
• W2980167008 hasAuthorship W2980167008A5031025260 @default.
• W2980167008 hasAuthorship W2980167008A5035867793 @default.
• W2980167008 hasAuthorship W2980167008A5039903831 @default.
• W2980167008 hasAuthorship W2980167008A5049170518 @default.
• W2980167008 hasAuthorship W2980167008A5049775425 @default.
• W2980167008 hasAuthorship W2980167008A5055756816 @default.
• W2980167008 hasAuthorship W2980167008A5072237091 @default.
• W2980167008 hasAuthorship W2980167008A5077817714 @default.
• W2980167008 hasAuthorship W2980167008A5086156727 @default.
• W2980167008 hasAuthorship W2980167008A5087009038 @default.
• W2980167008 hasConcept C101762097 @default.
• W2980167008 hasConcept C104317684 @default.
• W2980167008 hasConcept C111829193 @default.
• W2980167008 hasConcept C150194340 @default.
• W2980167008 hasConcept C2778461978 @default.
• W2980167008 hasConcept C2780914512 @default.
• W2980167008 hasConcept C502942594 @default.
• W2980167008 hasConcept C54355233 @default.
• W2980167008 hasConcept C86803240 @default.
• W2980167008 hasConceptScore W2980167008C101762097 @default.
• W2980167008 hasConceptScore W2980167008C104317684 @default.
• W2980167008 hasConceptScore W2980167008C111829193 @default.
• W2980167008 hasConceptScore W2980167008C150194340 @default.
• W2980167008 hasConceptScore W2980167008C2778461978 @default.
• W2980167008 hasConceptScore W2980167008C2780914512 @default.
• W2980167008 hasConceptScore W2980167008C502942594 @default.
• W2980167008 hasConceptScore W2980167008C54355233 @default.
• W2980167008 hasConceptScore W2980167008C86803240 @default.
• W2980167008 hasLocation W29801670081 @default.
• W2980167008 hasOpenAccess W2980167008 @default.
• W2980167008 hasPrimaryLocation W29801670081 @default.
• W2980167008 hasRelatedWork W1755674448 @default.
• W2980167008 hasRelatedWork W1990279644 @default.
• W2980167008 hasRelatedWork W1994598503 @default.
• W2980167008 hasRelatedWork W2009222274 @default.
• W2980167008 hasRelatedWork W2026422356 @default.
• W2980167008 hasRelatedWork W2069591815 @default.
• W2980167008 hasRelatedWork W2096996870 @default.
• W2980167008 hasRelatedWork W2128741634 @default.
• W2980167008 hasRelatedWork W2398008690 @default.
• W2980167008 hasRelatedWork W2487735175 @default.
• W2980167008 hasRelatedWork W2530511620 @default.
• W2980167008 hasRelatedWork W2536636704 @default.
• W2980167008 hasRelatedWork W2559979928 @default.
• W2980167008 hasRelatedWork W2591967451 @default.
• W2980167008 hasRelatedWork W2597371747 @default.
• W2980167008 hasRelatedWork W2908069525 @default.
• W2980167008 hasRelatedWork W2908713966 @default.
• W2980167008 hasRelatedWork W3108074576 @default.
• W2980167008 hasRelatedWork W3141186259 @default.
• W2980167008 hasRelatedWork W3158955857 @default.
• W2980167008 isParatext "false" @default.
• W2980167008 isRetracted "false" @default.
• W2980167008 magId "2980167008" @default.
• W2980167008 workType "article" @default.